SF3B1 and myelodysplastic syndrome: Another 20% of MDS patients carry mutations in genes, such as U2AF1, U2AF2, SF3B1, and ZRSF2. They co-occur with epigenetic mutations, indicating cooperation of these mutations, and resulting in a specific phenotype.